Key result
MK5 haplodeficiency reduced infarct size, scar area, and scar collagen content post-myocardial infarction.
Why the study?
Does MK5 haplodeficiency reduce infarct size and scar formation in post-myocardial infarction models?
Does MK5 haplodeficiency reduce infarct size and scar formation in post-myocardial infarction models?
MK5 haplodeficiency reduces infarct size and scar formation after myocardial infarction, suggesting MK5 as a potential therapeutic target for post-MI remodeling.
Hypothesis-generating for MK5 targeting in post-MI remodeling; clinical translation remains untested.
MK5/PRAK is a protein serine/threonine kinase activated by p38 MAPK and/or atypical MAPKs ERK3/4. MK5 haplodeficiency reduced infarct size, scar area, and scar collagen content post-myocardial infarction. Motility and proliferation were reduced in cultured MK5-null cardiac myofibroblasts.
No takes yet. Share an insight, caveat, or question.
Nawaito et al. (2019) studied this question. MK5 haplodeficiency reduced infarct size, scar area, and scar collagen content post-myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: